Trial intelligence / Profile preview

Percutaneous Cryotherapy for Painful Musculoskeletal Metastasis

NCT03441139Terminated

Sponsor
Centre Léon Bérard
Start
Jul 2018
Primary completion
May 2020
Countries
1
01

Overview

Randomised, open-label trial (2 arms), sponsored by Centre Léon Bérard. Primary endpoint: Time to analgesic strategy failure at 6 months. Started Jul 2018; status: terminated.

Beyond the preview

Go deeper on NCT03441139.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03441139.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call